Yi-Rong Liu Selected Research

Triple Negative Breast Neoplasms

1/2019	The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.
7/2016	Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
4/2016	Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer.
3/2016	Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
1/2016	Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Rong Liu Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2013
10	Neoplasms (Cancer) 10/2019 - 08/2015
5	Triple Negative Breast Neoplasms 01/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 08/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Lymphatic Metastasis 01/2019
1	Necrosis 01/2014
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2014

Drug/Important Bio-Agent (IBA)

6	Phenobarbital (Luminal)FDA Link 10/2019 - 09/2015
5	Hormones (Hormone)IBA 10/2018 - 04/2015
4	Estrogen ReceptorsIBA 04/2020 - 08/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2020 - 08/2015
3	human ERBB2 proteinIBA 01/2019 - 01/2016
3	Long Noncoding RNAIBA 01/2019 - 01/2016
3	Trastuzumab (Herceptin)FDA Link 10/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2014
2	Biological ProductsIBA 01/2018 - 08/2015
2	Androgen Receptors (Androgen Receptor)IBA 07/2016 - 03/2016
1	Formaldehyde (Formol)FDA Link 01/2022
1	Endothelial Protein C ReceptorIBA 10/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Tamoxifen FDA LinkGeneric 12/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2018
1	RNA Splicing FactorsIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	PhosphoproteinsIBA 10/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2016
1	taxaneIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 09/2015
1	StathminIBA 09/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2015
1	2,3,5- trimethyl- 6- (12- hydroxy- 5,10- dodecadiynyl)- 1,4- benzoquinoneIBA 01/2014
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014

Therapy/Procedure

5	Therapeutics 12/2018 - 08/2015
2	Mastectomy (Mammectomy) 08/2015 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2016
1	Segmental Mastectomy (Lumpectomy) 08/2015
1	Mammaplasty (Breast Reconstruction) 01/2013